These effects, along with a previous report demonstrating that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like conduct in mice,two guidance the strategy of focusing on ACKR3 as a novel method to modulate the opioid procedure, which could open up new therapeutic avenues for opioid-